Agios Pharmaceuticals, Inc.
Undisclosed program
Resolved
98days ago
Catalyst readout · ~ Mar 31, 2026 estimated
What's at stake
A key catalyst for Undisclosed program (its lead indication) is expected ~ Mar 31, 2026.
Primary source
· SEC 8-K
verified 16h ago
“Potential pre-sNDA meeting Q1 2026”